• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状RNA:一种用于人类三阴性乳腺癌的潜在诊断、预后和治疗生物标志物。

Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer.

作者信息

Tian Tian, Zhao Yangzhi, Zheng Jingying, Jin Shunzi, Liu Zhongshan, Wang Tiejun

机构信息

Department of Radiation Oncology, The Second Affiliated Hospital of Jilin University, Changchun 130041, China.

Department of Hematology, The First Hospital of Jilin University, Changchun 130021, China.

出版信息

Mol Ther Nucleic Acids. 2021 Jul 2;26:63-80. doi: 10.1016/j.omtn.2021.06.017. eCollection 2021 Dec 3.

DOI:10.1016/j.omtn.2021.06.017
PMID:34513294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8411013/
Abstract

Triple-negative breast cancer (TNBC), which is the most malignant subtype of breast cancer (BC), accounts for 10%-20% of all BC cases. TNBC, which occurs more frequently in young women, is characterized by high rates of cell proliferation and metastasis and poor prognosis. Chemotherapy is the primary systemic therapeutic strategy for TNBC. However, chemotherapy is largely unsuccessful, and effective targeted therapies for TNBC have not been established. Therefore, it is a matter of great urgency to identify precise molecular targets for the promising prognosis of patients with TNBC. Circular RNAs (circRNAs), which are a type of non-coding RNAs (ncRNAs), are abundantly expressed in the eukaryotic cells and exhibit diverse cellular functions. The roles of circRNAs are to sponge microRNA or RNA-binding proteins, regulate gene expression, and serve as templates for translation. Here, we review the current findings on the potential of circRNAs as a diagnostic, prognostic, and therapeutic biomarker for TNBC. However, further studies are essential to elucidate the functions of circRNAs in TNBC. This review also discusses the current limitations and future directions of TNBC-associated circRNAs, which can facilitate the translation of experimental research into clinical application.

摘要

三阴性乳腺癌(TNBC)是乳腺癌(BC)中最具侵袭性的亚型,占所有BC病例的10%-20%。TNBC在年轻女性中更为常见,其特点是细胞增殖和转移率高,预后较差。化疗是TNBC的主要全身治疗策略。然而,化疗在很大程度上并不成功,尚未建立针对TNBC的有效靶向治疗方法。因此,确定TNBC患者预后的精确分子靶点迫在眉睫。环状RNA(circRNAs)是一类非编码RNA(ncRNAs),在真核细胞中大量表达,并具有多种细胞功能。circRNAs的作用是充当微小RNA或RNA结合蛋白的海绵,调节基因表达,并作为翻译模板。在此,我们综述了circRNAs作为TNBC诊断、预后和治疗生物标志物潜力的当前研究结果。然而,进一步研究对于阐明circRNAs在TNBC中的功能至关重要。本综述还讨论了TNBC相关circRNAs的当前局限性和未来方向,这有助于将实验研究转化为临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ced/8411013/dd94656536f5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ced/8411013/36770af07456/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ced/8411013/6e7fc9986baa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ced/8411013/60b0ec2b5166/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ced/8411013/dd94656536f5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ced/8411013/36770af07456/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ced/8411013/6e7fc9986baa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ced/8411013/60b0ec2b5166/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ced/8411013/dd94656536f5/gr3.jpg

相似文献

1
Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer.环状RNA:一种用于人类三阴性乳腺癌的潜在诊断、预后和治疗生物标志物。
Mol Ther Nucleic Acids. 2021 Jul 2;26:63-80. doi: 10.1016/j.omtn.2021.06.017. eCollection 2021 Dec 3.
2
Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3.环状RNA hsa_circ_0044234作为三阴性乳腺癌独特的分子标志物:GATA3的潜在调节因子
Cancer Cell Int. 2021 Jun 14;21(1):312. doi: 10.1186/s12935-021-02015-6.
3
Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review.环状 RNA 作为三阴性乳腺癌的新型生物标志物:系统评价。
Mol Biol Rep. 2022 Oct;49(10):9825-9840. doi: 10.1007/s11033-022-07502-1. Epub 2022 May 10.
4
Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer.环状 RNA 在三阴性乳腺癌中的调控机制、功能及临床意义。
J Hematol Oncol. 2021 Mar 6;14(1):41. doi: 10.1186/s13045-021-01052-y.
5
The therapeutic potential of circular RNA in triple-negative breast cancer.环状RNA在三阴性乳腺癌中的治疗潜力。
Cancer Drug Resist. 2024 Apr 23;7:13. doi: 10.20517/cdr.2023.141. eCollection 2024.
6
circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a.环状 RNA(circRNA)GFRA1 和 GFRA1 通过调节 miR-34a 在三阴性乳腺癌中作为 ceRNA 发挥作用。
J Exp Clin Cancer Res. 2017 Oct 16;36(1):145. doi: 10.1186/s13046-017-0614-1.
7
circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression.环状 RNA EPSTI1 作为三阴性乳腺癌进展的预后标志物和介质。
Theranostics. 2018 Jul 1;8(14):4003-4015. doi: 10.7150/thno.24106. eCollection 2018.
8
circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.环状 KIF4A 作为一个预后因素和调节因子来调控三阴性乳腺癌的进展。
Mol Cancer. 2019 Feb 11;18(1):23. doi: 10.1186/s12943-019-0946-x.
9
Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.长非编码 RNA:在人类非三阴性和三阴性乳腺癌的靶向诊断、预后和改进治疗策略中的意义。
Clin Epigenetics. 2018 Jun 27;10:88. doi: 10.1186/s13148-018-0514-z. eCollection 2018.
10
Novel Insights into Circular RNAs in Metastasis in Breast Cancer: An Update.乳腺癌转移中环状RNA的新见解:最新进展
Noncoding RNA. 2023 Sep 16;9(5):55. doi: 10.3390/ncrna9050055.

引用本文的文献

1
Exploring the Potential and Advancements of Circular RNA Therapeutics.探索环状RNA疗法的潜力与进展。
Exploration (Beijing). 2025 May 1;5(4):e20240044. doi: 10.1002/EXP.20240044. eCollection 2025 Aug.
2
The Dual Roles of Circular RNAs in Breast Cancer Distant Metastasis and Their Clinical Applications.环状RNA在乳腺癌远处转移中的双重作用及其临床应用
J Cancer. 2025 Jul 11;16(10):3270-3282. doi: 10.7150/jca.111680. eCollection 2025.
3
Circular RNA profiling identifies circ_0001522, circ_0001278, and circ_0001801 as predictors of unfavorable prognosis and drivers of triple-negative breast cancer hallmarks.

本文引用的文献

1
CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer.环状 RNA NR3C2 通过海绵吸附 miR-513a-3p 促进三阴性乳腺癌中 HRD1 介导的肿瘤抑制作用。
Mol Cancer. 2021 Feb 2;20(1):25. doi: 10.1186/s12943-021-01321-x.
2
circGFRA1 affects the sensitivity of triple-negative breast cancer cells to paclitaxel via the miR-361-5p/TLR4 pathway.环状 RNA(circRNA)GFRA1 通过 miR-361-5p/TLR4 通路影响三阴性乳腺癌细胞对紫杉醇的敏感性。
J Biochem. 2021 Jul 3;169(5):601-611. doi: 10.1093/jb/mvaa148.
3
Screening for functional circular RNAs using the CRISPR-Cas13 system.
环状RNA分析确定circ_0001522、circ_0001278和circ_0001801为三阴性乳腺癌不良预后的预测指标和特征驱动因素。
Cell Death Discov. 2025 Jul 9;11(1):316. doi: 10.1038/s41420-025-02576-9.
4
CircSCD1 inhibits ferroptosis in breast Cancer through stabilizing SCD1 protein via deubiquitinase OTUB1.环状SCD1通过去泛素化酶OTUB1稳定SCD1蛋白来抑制乳腺癌中的铁死亡。
Sci Rep. 2025 Apr 10;15(1):12351. doi: 10.1038/s41598-025-96868-w.
5
Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications.乳腺癌中的非编码RNA:诊断和治疗意义
Int J Mol Sci. 2024 Dec 26;26(1):127. doi: 10.3390/ijms26010127.
6
The role of circRNAs in resistance to doxorubicin.环状 RNA 在对抗阿霉素耐药中的作用。
Cell Commun Signal. 2024 Nov 29;22(1):572. doi: 10.1186/s12964-024-01952-9.
7
Circ_0081723 enhances cervical cancer progression and modulates CREBRF via sponging miR-545-3p.环状 RNA 0081723 通过海绵吸附 miR-545-3p 增强宫颈癌进展并调节 CREBRF。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8839-8852. doi: 10.1007/s00210-024-03175-8. Epub 2024 Jun 8.
8
Inhibition of breast cancer cell growth and migration through siRNA-mediated modulation of circ_0009910/miR-145-5p/MUC1 axis.通过siRNA介导调控circ_0009910/miR-145-5p/MUC1轴抑制乳腺癌细胞生长和迁移
Noncoding RNA Res. 2024 Jan 26;9(2):367-375. doi: 10.1016/j.ncrna.2024.01.016. eCollection 2024 Jun.
9
Genomic Alterations Affecting Competitive Endogenous RNAs (ceRNAs) and Regulatory Networks (ceRNETs) with Clinical Implications in Triple-Negative Breast Cancer (TNBC).影响竞争性内源性RNA(ceRNAs)和调控网络(ceRNETs)的基因组改变及其在三阴性乳腺癌(TNBC)中的临床意义
Int J Mol Sci. 2024 Feb 23;25(5):2624. doi: 10.3390/ijms25052624.
10
CircSEPT9 promotes breast cancer progression by regulating PTBP3 expression via sponging miR-625-5p.环状 RNA SEPT9 通过海绵吸附 miR-625-5p 调控 PTBP3 表达促进乳腺癌进展。
Thorac Cancer. 2024 Apr;15(10):808-819. doi: 10.1111/1759-7714.15252. Epub 2024 Feb 26.
利用 CRISPR-Cas13 系统进行功能性环状 RNA 的筛选。
Nat Methods. 2021 Jan;18(1):51-59. doi: 10.1038/s41592-020-01011-4. Epub 2020 Dec 7.
4
Design and application of circular RNAs with protein-sponge function.具有蛋白质海绵功能的环状 RNA 的设计与应用。
Nucleic Acids Res. 2020 Dec 2;48(21):12326-12335. doi: 10.1093/nar/gkaa1085.
5
Non-coding RNA derived from extracellular vesicles in cancer immune escape: Biological functions and potential clinical applications.外泌体来源的非编码 RNA 在肿瘤免疫逃逸中的作用:生物学功能及潜在临床应用
Cancer Lett. 2021 Mar 31;501:234-246. doi: 10.1016/j.canlet.2020.11.005. Epub 2020 Nov 10.
6
CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis.环状UBE2D2(hsa_circ_0005728)通过调控miR-512-3p/CDCA3轴促进三阴性乳腺癌细胞的增殖、转移和化疗耐药。
Cancer Cell Int. 2020 Sep 14;20:454. doi: 10.1186/s12935-020-01547-7. eCollection 2020.
7
Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab.循环 HER2 RNA 阳性三阴性乳腺癌对 Pertuzumab 敏感。
Mol Cancer. 2020 Sep 11;19(1):142. doi: 10.1186/s12943-020-01259-6.
8
The future of cancer immunotherapy: microenvironment-targeting combinations.癌症免疫疗法的未来:靶向微环境的联合疗法。
Cell Res. 2020 Jun;30(6):507-519. doi: 10.1038/s41422-020-0337-2. Epub 2020 May 28.
9
The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.E2F1 和 EIF4A3 介导的 circRNA circSEPT9 促进三阴性乳腺癌的发生发展。
Mol Cancer. 2020 Apr 7;19(1):73. doi: 10.1186/s12943-020-01183-9.
10
Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance.环状 RNA 在癌症放化疗抵抗中的功能和作用机制。
Mol Cancer. 2020 Mar 14;19(1):58. doi: 10.1186/s12943-020-01180-y.